Contact
Please use this form to send email to PR contact of this press release:
MPI - FDA approves OVs IDE and IND for ovarian cancer with its PARP inhibitor and DRP
TO:
Please use this form to send email to PR contact of this press release:
MPI - FDA approves OVs IDE and IND for ovarian cancer with its PARP inhibitor and DRP
TO: